Boston Common Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,343
| Closed | -$17.3M | – | 311 |
|
|
2025
Q1 | $17.3M | Buy |
27,343
+5,525
| +25% | +$3.8M | 0.53% | 70 |
|
|
2024
Q4 | $15.5M | Sell |
21,818
-7,258
| -25% | -$6.09M | 0.45% | 84 |
|
|
2024
Q3 | $30.6M | Sell |
29,076
-3,296
| -10% | -$3.67M | 0.8% | 28 |
|
|
2024
Q2 | $34M | Sell |
32,372
-2,009
| -6% | -$1.95M | 0.87% | 22 |
|
|
2024
Q1 | $33.1M | Sell |
34,381
-8,271
| -19% | -$7.86M | 0.79% | 38 |
|
|
2023
Q4 | $37.5M | Sell |
42,652
-1,790
| -4% | -$1.47M | 0.85% | 34 |
|
|
2023
Q3 | $36.6M | Sell |
44,442
-4,096
| -8% | -$3.22M | 0.87% | 30 |
|
|
2023
Q2 | $34.9M | Sell |
48,538
-2,689
| -5% | -$2.07M | 0.74% | 39 |
|
|
2023
Q1 | $42.1M | Sell |
51,227
-3,140
| -6% | -$2.37M | 0.88% | 29 |
|
|
2022
Q4 | $39.2M | Buy |
54,367
+474
| +0.9% | +$350K | 1.88% | 5 |
|
|
2022
Q3 | $37.1M | Sell |
53,893
-5,539
| -9% | -$3.49M | 1.95% | 5 |
|
|
2022
Q2 | $35.1M | Buy |
59,432
+16,713
| +39% | +$10.9M | 1.75% | 9 |
|
|
2022
Q1 | $29.8M | Buy |
42,719
+647
| +2% | +$409K | 1.29% | 18 |
|
|
2021
Q4 | $26.6M | Buy |
42,072
+312
| +0.7% | +$192K | 1.07% | 28 |
|
|
2021
Q3 | $25.3M | Buy |
41,760
+189
| +0.5% | +$117K | 1.09% | 29 |
|
|
2021
Q2 | $23.2M | Buy |
41,571
+16,466
| +66% | +$8.34M | 1% | 36 |
|
|
2021
Q1 | $11.9M | Buy |
25,105
+13,467
| +116% | +$6.56M | 0.75% | 44 |
|
|
2020
Q4 | $5.62M | Buy |
11,638
+536
| +5% | +$289K | 0.39% | 78 |
|
|
2020
Q3 | $6.21M | Sell |
11,102
-56
| -0.5% | -$34K | 0.59% | 51 |
|
|
2020
Q2 | $6.96M | Sell |
11,158
-273
| -2% | -$155K | 0.74% | 44 |
|
|
2020
Q1 | $5.58M | Sell |
11,431
-4,445
| -28% | -$1.83M | 0.79% | 45 |
|
|
2019
Q4 | $5.96M | Sell |
15,876
-619
| -4% | -$208K | 0.69% | 54 |
|
|
2019
Q3 | $4.58M | Sell |
16,495
-670
| -4% | -$198K | 0.57% | 69 |
|
|
2019
Q2 | $5.37M | Buy |
17,165
+4,298
| +33% | +$1.43M | 0.67% | 57 |
|
|
2019
Q1 | $5.28M | Sell |
12,867
-266
| -2% | -$110K | 0.69% | 57 |
|
|
2018
Q4 | $4.91M | Buy |
13,133
+2,815
| +27% | +$1.03M | 0.72% | 53 |
|
|
2018
Q3 | $4.17M | Sell |
10,318
-1,181
| -10% | -$449K | 0.52% | 74 |
|
|
2018
Q2 | $3.97M | Sell |
11,499
-475
| -4% | -$149K | 0.49% | 73 |
|
|
2018
Q1 | $4.12M | Buy |
11,974
+123
| +1% | +$42.8K | 0.49% | 76 |
|
|
2017
Q4 | $4.46M | Buy |
11,851
+266
| +2% | +$108K | 0.53% | 74 |
|
|
2017
Q3 | $5.18M | Sell |
11,585
-85
| -0.7% | -$40.4K | 0.65% | 64 |
|
|
2017
Q2 | $5.73M | Sell |
11,670
-3,323
| -22% | -$1.45M | 0.75% | 50 |
|
|
2017
Q1 | $5.81M | Buy |
14,993
+3,295
| +28% | +$1.22M | 0.79% | 40 |
|
|
2016
Q4 | $4.29M | Buy |
11,698
+106
| +0.9% | +$40.3K | 0.63% | 58 |
|
|
2016
Q3 | $4.66M | Buy |
11,592
+2,431
| +27% | +$975K | 0.25% | 121 |
|
|
2016
Q2 | $3.2M | Buy |
9,161
+4,373
| +91% | +$1.68M | 0.18% | 144 |
|
|
2016
Q1 | $1.73M | Buy |
+4,788
| New | +$1.97M | 0.1% | 158 |
|
Other funds holding REGN
